Research on heart failure in Colombia, time to take a step forward

Pabón, Guillermo Mora

doi:10.15446/revfacmed.v66n2.70828

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Even though healthcare coverage in Colombia for 2019 was 95% ensured either by the contributive regime (includes mandatory payments from employers) or by subsidized regime (set up initially for people outside the formal sector and with very low income) [ 7 ], in regions such as Orinoco or Amazonas, health coverage falls under 70% [ 8 9 ]. Despite the fact that HF medication is guaranteed in the health benefit program [ 10 ], information regarding the health resource utilization associated with this condition in Colombia is scarce, and there is little evidence related to the epidemiology of HF in Colombia [ 11 12 ]. That is why a national HF registry can provide valuable epidemiological data.…”

Section: Introductionmentioning

confidence: 99%

Characteristics and Outcomes of Heart Failure Patients from a Middle-Income Country: The RECOLFACA Registry

Gómez-Mesa

Saldarriaga

Echeverría

et al. 2022

View full text Add to dashboard Cite

Background: There is a lack of epidemiological data around heart failure (HF) in Latin America; the potential impact description of this disease in middle-income countries is relevant.Objective: This study aimed to describe the characteristics and healthcare resource utilization patterns of HF patients at baseline and six-month follow-up. Methods:This retrospective observational study used data from the RECOLFACA (Registro Colombiano de Falla Cardíaca) registry, which includes data obtained from the examination of clinical records from 2,528 patients in 60 Colombian healthcare institutions. Baseline and six-month follow-up data were evaluated from patients with previous hospital admissions due to HF during the 12 months prior to enrollment.Results: This study analyzed 2,045 patients (42.8% female) with a mean age of 67.71 ± 13.64 years. The most common etiologies were ischemic (44.4%) and hypertensive heart disease (38.5%). At baseline, 53.4% of patients were classified with NYHA class II, and 73.6% had a reduced left ventricle ejection fraction (LVEF). A year prior to entering the registry, patients were hospitalized an average of 1.4 ± 1.1 times due to HF. Prescription of evidence-based treatment at baseline included sacubitril/valsartan (10%), ACEI (33%), ARB (41%), beta-blocker (79%), diuretics (68%), and MRA (56%). The average quality of life score measured using the EQ-5D-3L questionnaire was 78.7 ± 20.8 at baseline and 82.3 ± 20.1 at the six-month follow-up. The mortality rate was 6.7%. Conclusions:The use of information from the RECOLFACA registry allowed characterization as well as analyses of healthcare resource utilization of patients with heart failure in Colombia. The results of this study show that multiple evidence-based treatments for HF are being widely used in Colombia, but there seems to be room for improvement regarding some interventions for the treatment of patients with HF. 2 Gomez-Mesa et al.

show abstract

Section: Introductionmentioning

confidence: 99%

Characteristics and Outcomes of Heart Failure Patients from a Middle-Income Country: The RECOLFACA Registry

Gómez-Mesa

Saldarriaga

Echeverría

et al. 2022

View full text Add to dashboard Cite

show abstract

“…En Colombia desde la década de los 1980's las ECV han liderado las principales causas de muerte, siendo la más importante las enfermedades isquémicas cardiacas, además de otras ENT ubicadas entre las diez primeras como el accidente cerebrovascular, la diabetes y la enfermedad hipertensiva 5 . Durante el periodo 1998-2011 la tasa estandarizada de mortalidad por ECV fue de 104,6 defunciones x 100.000 con una clara tendencia descendente de 108,6 defunciones en 1998 a 95,9 en 2011.…”

Section: Temas Livres Free Themes Introducciónunclassified

Desigualdades socioeconómicas en la mortalidad por enfermedades cardiovasculares: Región Pacifico de Colombia, 2002-2015

Pérez-Flórez

Achcar

2021

Ciênc. saúde coletiva

View full text Add to dashboard Cite

Resumen Las enfermedades cardiovasculares (ECV) son la principal causa de muerte en el mundo y en Colombia siendo consideradas un serio problema de salud pública. El objetivo de este estudio fue analizar espacial y temporalmente la mortalidad por ECV en la región Pacifico de Colombia durante el periodo 2002-2015 y su asociación con algunos indicadores socioeconómicos municipales usando técnicas estadísticas de análisis espacial. Fue un estudio descriptivo-ecológico en los 177 municipios de la región Pacifico que usó datos de mortalidad por ECV, bajo los códigos I00-I99 de la Clasificación Internacional de Enfermedades (CIE-10), y siete indicadores socioeconómicos municipales. El análisis incluyó cálculo de tasas de mortalidad crudas y estandarizadas, según sexo, para las ECV y sus principales causas, y la modelación del conteo de defunciones usando modelos jerárquicos Bayesianos. Durante el periodo 2002-2015 las tasas estandarizadas de mortalidad por ECV mostraron una tendencia descendente en hombres (129,0 a 119,3) y en mujeres (129,0 a 110,0) siendo las principales causas de muerte las enfermedades isquémicas del corazón, seguidas de las cerebrovasculares. En general, el riesgo de mortalidad por ECV fue mayor en los municipios menos favorecidos económica y socialmente.

show abstract

Research on heart failure in Colombia, time to take a step forward

Cited by 2 publications

References 6 publications

Characteristics and Outcomes of Heart Failure Patients from a Middle-Income Country: The RECOLFACA Registry

Characteristics and Outcomes of Heart Failure Patients from a Middle-Income Country: The RECOLFACA Registry

Desigualdades socioeconómicas en la mortalidad por enfermedades cardiovasculares: Región Pacifico de Colombia, 2002-2015

Contact Info

Product

Resources

About